Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review

doi:10.1186/1475-2840-4-1

Cardiovascular Diabetology

Volume 4

Viewing options:

Associated material:

Readers' comments (1)
PubMed record

Related literature:

Articles citing this article
on BioMed Central
on Google Scholar
on PubMed Central
Other articles by authors
on Google Scholar

Hayden MR
Tyagi SC

on PubMed

Hayden MR
Tyagi SC
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Comments(1)

Important error in manuscript regarding low HDL-C

Melvin Hayden (10 January 2005) Department of Family and Community Medicine, University of Missouri School of Medicine

The chemistry profile of 2004 is in error.

The uric acid level is reported to be 6.5 mg/dL with global risk reduction and this is in error.

The correct uric acid level following global risk reduction is 3.5 mg/dL in 2004

Elevations of uric acid levels greater than 4 mg/dL are to be considered a red flag and more agressive therapy should be initiated.

Hayden MR, Tyagi SC: Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle.

Nutr Metab (Lond). 2004 Oct 19;1(1):10

Competing interests

NONE

top

Comments(1)

Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review

Important error in manuscript regarding low HDL-C

Have something to say? Post a comment on this article!